908 Devices is a company offering handheld and desktop mass spec devices for chemical and biomolecular analysis. It offers a range of products, including rugged, handheld chemical detection tools, compact footprint analyzers, and fast separation devices. The company serves various industries, such as safety and security, oil and gas, life sciences, and other applied markets.
|HQ||Boston, MA, US||Map|
Gross profit (Q1, 2021)
Gross profit margin (Q1, 2021), %
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (15-Oct-2021)
Closing stock price (15-Oct-2021)
908 Devices revenue breakdown by business segment: 14.6% from License and Contract, 12.8% from Consumables and Service and 72.5% from Device Sales
908 Devices revenue breakdown by geographic segment: 7.4% from Asia Pacific, 16.4% from EMEA and 76.2% from North America
908 Devices has 881 Twitter Followers. The number of followers has increased 0.7% month over month and increased 2.1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was 908 Devices founded?
908 Devices was founded in 2012.
Who are 908 Devices key executives?
908 Devices's key executives are Kevin J. Knopp, Christopher D. Brown and Joseph H. Griffith.
How many employees does 908 Devices have?
908 Devices has 96 employees.
What is 908 Devices revenue?
Latest 908 Devices annual revenue is $18 m.
What is 908 Devices revenue per employee?
Latest 908 Devices revenue per employee is $187.2 k.
Who are 908 Devices competitors?
Competitors of 908 Devices include Clinical Trials of Texas, INFICON and Danaher.
Where is 908 Devices headquarters?
908 Devices headquarters is located at 645 Summer St, Boston.
Where are 908 Devices offices?
908 Devices has an office in Boston.
How many offices does 908 Devices have?
908 Devices has 1 office.
Receive alerts for 300+ data fields across thousands of companies